Avail upto 30% off on all reports till July 31st.

Global Biosimilar Monoclonal Antibodies Market Insights, Forecast to 2025

Date: Apr 10 2019
|
QYRESEARCH
|
Number of Pages: 118
|
Category: Pharma & Healthcare

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
The classification of Biosimilar Monoclonal Antibodies includes Infliximab, Rituximab, Trastuzumab, Adalimumab and Other, and the sales proportion of Infliximab in 2017 is about 36.5%.
Biosimilar Monoclonal Antibodies is widely used for Oncology, Autoimmune Disease and Others. The most proportion of Biosimilar Monoclonal Antibodies is sales in Autoimmune Disease, and the consumption proportion is about 85.6% in 2017.
The global Biosimilar Monoclonal Antibodies market is valued at 2750 million US$ in 2018 and will reach 15200 million US$ by the end of 2025, growing at a CAGR of 27.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biosimilar Monoclonal Antibodies market based on company, product type, end user and key regions.

This report studies the global market size of Biosimilar Monoclonal Antibodies in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilar Monoclonal Antibodies in these regions.
This research report categorizes the global Biosimilar Monoclonal Antibodies market by top players/brands, region, type and end user. This report also studies the global Biosimilar Monoclonal Antibodies market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals

Market size by Product
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Market size by End User
Oncology
Autoimmune Disease
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Biosimilar Monoclonal Antibodies market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Biosimilar Monoclonal Antibodies market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biosimilar Monoclonal Antibodies companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Biosimilar Monoclonal Antibodies submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Biosimilar Monoclonal Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biosimilar Monoclonal Antibodies market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Study Coverage
    1.1 Biosimilar Monoclonal Antibodies Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
           1.4.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Product
           1.4.2 Infliximab
           1.4.3 Rituximab
           1.4.4 Trastuzumab
           1.4.5 Adalimumab
           1.4.6 Other
    1.5 Market by End User
           1.5.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by End User
           1.5.2 Oncology
           1.5.3 Autoimmune Disease
           1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered
2 Executive Summary
    2.1 Global Biosimilar Monoclonal Antibodies Market Size
           2.1.1 Global Biosimilar Monoclonal Antibodies Revenue 2014-2025
           2.1.2 Global Biosimilar Monoclonal Antibodies Sales 2014-2025
    2.2 Biosimilar Monoclonal Antibodies Growth Rate by Regions
           2.2.1 Global Biosimilar Monoclonal Antibodies Sales by Regions
           2.2.2 Global Biosimilar Monoclonal Antibodies Revenue by Regions
3 Breakdown Data by Manufacturers
    3.1 Biosimilar Monoclonal Antibodies Sales by Manufacturers
           3.1.1 Biosimilar Monoclonal Antibodies Sales by Manufacturers
           3.1.2 Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers
           3.1.3 Global Biosimilar Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
    3.2 Biosimilar Monoclonal Antibodies Revenue by Manufacturers
           3.2.1 Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2014-2019)
           3.2.2 Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
    3.3 Biosimilar Monoclonal Antibodies Price by Manufacturers
    3.4 Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Product Types
           3.4.1 Biosimilar Monoclonal Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
           3.4.2 Manufacturers Biosimilar Monoclonal Antibodies Product Type
           3.4.3 Date of International Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
    4.1 Global Biosimilar Monoclonal Antibodies Sales by Product
    4.2 Global Biosimilar Monoclonal Antibodies Revenue by Product
    4.3 Biosimilar Monoclonal Antibodies Price by Product
5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Biosimilar Monoclonal Antibodies Breakdown Data by End User
6 North America
    6.1 North America Biosimilar Monoclonal Antibodies by Countries
           6.1.1 North America Biosimilar Monoclonal Antibodies Sales by Countries
           6.1.2 North America Biosimilar Monoclonal Antibodies Revenue by Countries
           6.1.3 United States
           6.1.4 Canada
           6.1.5 Mexico
    6.2 North America Biosimilar Monoclonal Antibodies by Product
    6.3 North America Biosimilar Monoclonal Antibodies by End User
7 Europe
    7.1 Europe Biosimilar Monoclonal Antibodies by Countries
           7.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Countries
           7.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Countries
           7.1.3 Germany
           7.1.4 France
           7.1.5 UK
           7.1.6 Italy
           7.1.7 Russia
    7.2 Europe Biosimilar Monoclonal Antibodies by Product
    7.3 Europe Biosimilar Monoclonal Antibodies by End User
8 Asia Pacific
    8.1 Asia Pacific Biosimilar Monoclonal Antibodies by Countries
           8.1.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Countries
           8.1.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Countries
           8.1.3 China
           8.1.4 Japan
           8.1.5 Korea
           8.1.6 India
           8.1.7 Australia
           8.1.8 Indonesia
           8.1.9 Malaysia
           8.1.10 Philippines
           8.1.11 Thailand
           8.1.12 Vietnam
           8.1.13 Singapore
    8.2 Asia Pacific Biosimilar Monoclonal Antibodies by Product
    8.3 Asia Pacific Biosimilar Monoclonal Antibodies by End User
9 Central & South America
    9.1 Central & South America Biosimilar Monoclonal Antibodies by Countries
           9.1.1 Central & South America Biosimilar Monoclonal Antibodies Sales by Countries
           9.1.2 Central & South America Biosimilar Monoclonal Antibodies Revenue by Countries
           9.1.3 Brazil
    9.2 Central & South America Biosimilar Monoclonal Antibodies by Product
    9.3 Central & South America Biosimilar Monoclonal Antibodies by End User
10 Middle East and Africa
    10.1 Middle East and Africa Biosimilar Monoclonal Antibodies by Countries
           10.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Countries
           10.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries
           10.1.3 GCC Countries
           10.1.4 Turkey
           10.1.5 Egypt
           10.1.6 South Africa
    10.2 Middle East and Africa Biosimilar Monoclonal Antibodies by Product
    10.3 Middle East and Africa Biosimilar Monoclonal Antibodies by End User
11 Company Profiles
    11.1 Celltrion
           11.1.1 Celltrion Company Details
           11.1.2 Company Business Overview
           11.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
           11.1.4 Celltrion Biosimilar Monoclonal Antibodies Products Offered
           11.1.5 Celltrion Recent Development
    11.2 Pfizer (Hospira)
           11.2.1 Pfizer (Hospira) Company Details
           11.2.2 Company Business Overview
           11.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
           11.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Products Offered
           11.2.5 Pfizer (Hospira) Recent Development
    11.3 3SBIO
           11.3.1 3SBIO Company Details
           11.3.2 Company Business Overview
           11.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
           11.3.4 3SBIO Biosimilar Monoclonal Antibodies Products Offered
           11.3.5 3SBIO Recent Development
    11.4 Novartis (Sandoz)
           11.4.1 Novartis (Sandoz) Company Details
           11.4.2 Company Business Overview
           11.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
           11.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Products Offered
           11.4.5 Novartis (Sandoz) Recent Development
    11.5 Dr Reddy’s
           11.5.1 Dr Reddy’s Company Details
           11.5.2 Company Business Overview
           11.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
           11.5.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Products Offered
           11.5.5 Dr Reddy’s Recent Development
    11.6 Celgen Biopharma
           11.6.1 Celgen Biopharma Company Details
           11.6.2 Company Business Overview
           11.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
           11.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Products Offered
           11.6.5 Celgen Biopharma Recent Development
    11.7 Cadila Healthcare
           11.7.1 Cadila Healthcare Company Details
           11.7.2 Company Business Overview
           11.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
           11.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Products Offered
           11.7.5 Cadila Healthcare Recent Development
    11.8 Hisun Pharma
           11.8.1 Hisun Pharma Company Details
           11.8.2 Company Business Overview
           11.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
           11.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Products Offered
           11.8.5 Hisun Pharma Recent Development
    11.9 Torrent Pharmaceuticals
           11.9.1 Torrent Pharmaceuticals Company Details
           11.9.2 Company Business Overview
           11.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2014-2019)
           11.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Products Offered
           11.9.5 Torrent Pharmaceuticals Recent Development
12 Future Forecast
    12.1 Biosimilar Monoclonal Antibodies Market Forecast by Regions
           12.1.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions 2019-2025
           12.1.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Regions 2019-2025
    12.2 Biosimilar Monoclonal Antibodies Market Forecast by Product
           12.2.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Product 2019-2025
           12.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Product 2019-2025
    12.3 Biosimilar Monoclonal Antibodies Market Forecast by End User
    12.4 North America Biosimilar Monoclonal Antibodies Forecast
    12.5 Europe Biosimilar Monoclonal Antibodies Forecast
    12.6 Asia Pacific Biosimilar Monoclonal Antibodies Forecast
    12.7 Central & South America Biosimilar Monoclonal Antibodies Forecast
    12.8 Middle East and Africa Biosimilar Monoclonal Antibodies Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Biosimilar Monoclonal Antibodies Customers
    14.3 Sales Channels Analysis
           14.3.1 Sales Channels
           14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
    16.1 Research Methodology
           16.1.1 Methodology/Research Approach
           16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables and Figures
Figure Biosimilar Monoclonal Antibodies Product Picture
Table Biosimilar Monoclonal Antibodies Market Segments
Table Key Manufacturers Biosimilar Monoclonal Antibodies Covered
Table Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Product 2014-2025
Figure Infliximab Product Picture
Table Major Manufacturers of Infliximab
Figure Rituximab Product Picture
Table Major Manufacturers of Rituximab
Figure Trastuzumab Product Picture
Table Major Manufacturers of Trastuzumab
Figure Adalimumab Product Picture
Table Major Manufacturers of Adalimumab
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Oncology
Figure Autoimmune Disease
Figure Other
Figure Biosimilar Monoclonal Antibodies Report Years Considered
Figure Global Biosimilar Monoclonal Antibodies Market Size 2014-2025 (Million US$)
Figure Global Biosimilar Monoclonal Antibodies Sales 2014-2025 (K Units)
Table Global Biosimilar Monoclonal Antibodies Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Biosimilar Monoclonal Antibodies Sales by Regions 2014-2019 (K Units)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions 2014-2019
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions 2014-2019
Figure 2018 Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions
Table Global Biosimilar Monoclonal Antibodies Revenue by Regions 2014-2019 (Million US$)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions 2014-2019
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions 2014-2019
Figure 2018 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions
Table Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2014-2019) (K Units)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2014-2019)
Figure Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2014-2019) (Million USD)
Table Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
Figure Biosimilar Monoclonal Antibodies Value Share by Manufacturers in 2018
Table Key Manufacturers Biosimilar Monoclonal Antibodies Price (2014-2019) (USD/Unit)
Table Biosimilar Monoclonal Antibodies Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biosimilar Monoclonal Antibodies Product Type
Table Date of International Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
Table Global Biosimilar Monoclonal Antibodies Sales Share by Product (2014-2019)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Product in 2018
Table Global Biosimilar Monoclonal Antibodies Revenue by Product (2014-2019) (Million US$)
Table Global Biosimilar Monoclonal Antibodies Revenue Share by Product (2014-2019)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Product (2014-2019)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Product in 2018
Table Biosimilar Monoclonal Antibodies Price by Product 2014-2019 (USD/Unit)
Table Global Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
Table Global Biosimilar Monoclonal Antibodies Sales Share by End User (2014-2019)
Figure Global Sales Biosimilar Monoclonal Antibodies Market Share by End User (2014-2019)
Figure Global Sales Biosimilar Monoclonal Antibodies Market Share by End User in 2018
Figure North America Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure North America Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table North America Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 North America Biosimilar Monoclonal Antibodies Sales Market Share by Countries
Table North America Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
Table North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
Figure United States Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure United States Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Canada Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table North America Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
Table North America Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 North America Biosimilar Monoclonal Antibodies Market Share by Product
Table North America Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
Table North America Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 North America Biosimilar Monoclonal Antibodies Market Share by End User
Figure Europe Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Countries
Table Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
Table Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
Figure Germany Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Germany Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure France Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure France Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure UK Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Italy Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Russia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 Europe Biosimilar Monoclonal Antibodies Market Share by Product
Table Europe Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 Europe Biosimilar Monoclonal Antibodies Market Share by End User
Figure Asia Pacific Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Countries
Table Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
Figure China Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure China Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Japan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Korea Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure India Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure India Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Australia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Biosimilar Monoclonal Antibodies Market Share by Product
Table Asia Pacific Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
Table Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Biosimilar Monoclonal Antibodies Market Share by End User
Figure Central & South America Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Countries
Table Central & South America Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
Figure Brazil Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Biosimilar Monoclonal Antibodies Market Share by Product
Table Central & South America Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
Table Central & South America Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Biosimilar Monoclonal Antibodies Market Share by End User
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Countries
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Countries
Figure GCC Countries Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Biosimilar Monoclonal Antibodies Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Biosimilar Monoclonal Antibodies Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Monoclonal Antibodies Market Share by Product
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Biosimilar Monoclonal Antibodies Market Share by End User
Table Celltrion Company Details
Table Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Recent Development
Table Pfizer (Hospira) Company Details
Table Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer (Hospira) Recent Development
Table 3SBIO Company Details
Table 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table 3SBIO Recent Development
Table Novartis (Sandoz) Company Details
Table Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis (Sandoz) Recent Development
Table Dr Reddy’s Company Details
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Dr Reddy’s Recent Development
Table Celgen Biopharma Company Details
Table Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Celgen Biopharma Recent Development
Table Cadila Healthcare Company Details
Table Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cadila Healthcare Recent Development
Table Hisun Pharma Company Details
Table Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Hisun Pharma Recent Development
Table Torrent Pharmaceuticals Company Details
Table Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Torrent Pharmaceuticals Recent Development
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions 2019-2025 (K Units)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Regions 2019-2025
Table Global Biosimilar Monoclonal Antibodies Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Regions 2019-2025
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Product 2019-2025 (K Units)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Product 2019-2025
Table Global Biosimilar Monoclonal Antibodies Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Product 2019-2025
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by End User 2019-2025 (K Units)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by End User 2019-2025
Figure North America Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Biosimilar Monoclonal Antibodies Value Chain
Table Biosimilar Monoclonal Antibodies Customers List
Table Biosimilar Monoclonal Antibodies Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 48-72 hours. (Mon-Fri IST)

Select License Type

Why Choose InForGrowth?
  • Customer Insights
  • Market Opportunity Mapping
  • Competitive Intelligence for Key Companies
  • Market Entry Strategy
  • Product Mix and Pricing
  • Segmentation Analysis
  • Benchmarking Research based on Ecosystem and Interconnectivity
  • Market Attractiveness Framework
  • Demand-Supply Scenario & Performance Optimization
  • Technology Landscape & Revenue Augmenting Plans
  • Impact of Circular Economy or Digital Transformation Trends
  • Region Specific Reports / Country Specific Reports for Specific Topics
  • As Per Customer Need Section Wise Reports
  • Subscription Service with Real-Time Updates
  • Access to all the Research Studies in the Chosen Domains/Verticals
  • Pre and Post-Sales Service and Support
Need Help?
+
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.